Sangamo Therapeutics
SGMO
₹51.99
Share price
2.46%
Change (1 day)
-32.53%
Change (1 year)
Market capitalization of Sangamo Therapeutics (SGMO)
Market cap: ₹12.75 Billion
As of July 2025 Sangamo Therapeutics has a market cap of ₹12.75 Billion. This makes Sangamo Therapeutics the world's 8911th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Sangamo Therapeutics from 2000 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | ₹12.75 B | -72.16% |
| 2024 | ₹45.82 B | 471.25% |
| 2023 | ₹8.02 B | -81.16% |
| 2022 | ₹42.58 B | -47.64% |
| 2021 | ₹81.32 B | -49.62% |
| 2020 | ₹161.42 B | 133.2% |
| 2019 | ₹69.22 B | -15.61% |
| 2018 | ₹82.02 B | -7.32% |
| 2017 | ₹88.50 B | 504.65% |
| 2016 | ₹14.63 B | -65.71% |
| 2015 | ₹42.68 B | -35.88% |
| 2014 | ₹66.57 B | 24.64% |
| 2013 | ₹53.41 B | 205.92% |
| 2012 | ₹17.45 B | 121.48% |
| 2011 | ₹7.88 B | -41.61% |
| 2010 | ₹13.50 B | 9.24% |
| 2009 | ₹12.35 B | 80.31% |
| 2008 | ₹6.85 B | -66.73% |
| 2007 | ₹20.60 B | 101.1% |
| 2006 | ₹10.24 B | 84.78% |
| 2005 | ₹5.54 B | -15.57% |
| 2004 | ₹6.56 B | 5.66% |
| 2003 | ₹6.21 B | 74.03% |
| 2002 | ₹3.57 B | -67.63% |
| 2001 | ₹11.03 B | -45.26% |
| 2000 | ₹20.15 B |
End of Day market cap according to different sources
On Jul 28th, 2025 the market cap of Sangamo Therapeutics was reported to be:
₹12.12 Billion
₹12.75 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | ₹12.524 T | 98,068.87% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | ₹3.669 T | 28,661.46% | 🇺🇸 USA |
 Amgen AMGN | ₹14.037 T | 109,927.24% | 🇺🇸 USA |
 Biogen BIIB | ₹1.641 T | 12,765.38% | 🇺🇸 USA |
 Dow DOW | ₹1.579 T | 12,277.23% | 🇺🇸 USA |
 Johnson & Johnson JNJ | ₹34.686 T | 271,776.53% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | ₹966.12 B | 7,472.51% | 🇺🇸 USA |
 Merck MRK | ₹18.289 T | 143,254.69% | 🇺🇸 USA |